00088-1209 Anzemet - CanMED: NDC

Product NDC:

00088-1209

Brand Name:

Anzemet

Generic Name:

Dolasetron mesylate

Dosage Form Name:

Injection

Administration Route:

Intravenous

Substances:

Name: Dolasetron mesylate

Strength: 500.0

Unit: mg/25mL

Packages:

Code: 00088-1209-26

Description: 25 mL in 1 VIAL, MULTI-DOSE (0088-1209-26)

Effective Date: Sept. 11, 1997

Discontinued: June 30, 2016

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox